Skip to main content

Table 3 Multivariable analysis of the factors associated with HCC prevalence in non-cirrhotic NAFLD

From: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study

  Noncirrhotic NAFLD
Adjusted ORa 95% CI P value
Age > 65 years 3.37 2.47–4.59 < 0.001
Male gender 2.57 1.88–3.49 < 0.001
Non-Hispanic white 0.67 0.47–0.97 0.036
Non-Hispanic black 0.74 0.45–1.23 0.245
Hispanic 1.32 0.91–1.91 0.150
Diabetes 1.56 1.15–2.11 0.004
Hypertension 1.24 0.84–1.83 0.278
Hyperlipidemia 0.95 0.66–1.37 0.793
Obese 0.84 0.62–1.13 0.252
Morbid obese 1.06 0.81–1.39 0.658
Smoker 1.75 1.23–2.49 0.002
High ALT 2.69 2.14–3.37 < 0.001
  1. ALT alanine aminotransferases, CI confidence interval, HCC hepatocellular carcinoma, NAFLD non-alcoholic fatty liver disease, OR odds ratio
  2. aFactors adjusted with age, gender and white race